Hormone Replacement Therapy (HRT) in Menopause: Benefits, Risks & Decision Guide

The decision to use hormone replacement therapy (HRT) during menopause is highly individual and should be made in partnership with a healthcare provider. HRT effectively relieves moderate to severe vasomotor symptoms (hot flashes, night sweats) and can prevent bone loss, reducing osteoporosis risk. Some evidence suggests potential cardiovascular benefits when started early in menopause.

However, HRT carries risks, including increased incidence of venous thromboembolism (blood clots), stroke, and certain cancers (breast, endometrial with estrogen-only therapy). Risk profiles vary by age, time since menopause, route of administration (transdermal vs. oral), and personal/family medical history.

Current guidelines recommend HRT primarily for women with bothersome symptoms who are under 60 or within 10 years of menopause onset and have no contraindications. For women with mild symptoms or higher risk profiles, non-hormonal options (lifestyle changes, SSRIs/SNRIs, gabapentin, cognitive behavioral therapy) are preferred first-line approaches. Regular reassessment of benefits versus risks is essential.

Women's Health - Related Articles